How Brazilian Chiropractors Are Facing the COVID-19 Pandemic

August 30, 2020 updated by: Marcelo Borges Botelho, Trate - Tratamentos Especializados

How Brazilian Chiropractors Are Being Affected and What Strategies They Have Developed for Facing the COVID-19 Pandemic

Brazil has the Latin America's largest coronavirus outbreak, numbers second only to the United States in the western hemisphere. The first COVID-19 confirmed case in Brazil was on February of 2020. A 61yrs old man tested positive after returning from a trip to Italy. Few other very first cases were also imported from Europe by returning travelers. The first locally transmitted case was registered on March of 2020, when a total of 8 cases have already been confirmed. At the time the WHO declares the outbreak as a pandemic (March 11) Brazil had 52 confirmed cases being 6 of those locally transmitted.

Healthcare professionals are now more important than ever. Given the intrinsic nature of the hands-on treatment of the Chiropractic profession, it is extremely important to understand what strategies chiropractors have put in place to address patient care, safety, and self report COVID contamination of those professionals.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

948

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All chiropractors from the Brazilian Chiropractic association database / thru social media / principal investigator database will be invited to participate.

Description

Inclusion Criteria:

  • Chiropractors graduated from national or international accredited colleges.

Exclusion Criteria:

  • Chiropractors who did not treated patients in 2020.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Brazilian chiropractors
A cross-sectional survey will be performed with this population (Brazilian chiropractors) to assess outcomes regarding what is the current impact and what measures they have implemented while facing the COVID-19 pandemic.
Other: Electronic survey
Brazilian chiropractors will be invited by email and social media to answer an electronic survey.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
What measures have been implemented to avoid SARS-COV2 transmission when taking care of patients, during the COVID-19 pandemic.
Time Frame: 2 weeks
Subjects will answer a online survey addressing what measures they have implemented to prevent SARS-COV2 contamination among staff and patients, when taking care of patients. These questions address the use of individual protection devices, sanitizing methods, social distancing, patient orientation, and consultation time. These will be analyzed in conjunct, using descriptive statistics.
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Professionals SARS-COV2 infection rates.
Time Frame: 2 weeks
Self declared SARS-COV2 infection rates.
2 weeks
Professional financial impact.
Time Frame: 2 weeks
To assess the potential professional financial impact caused by the pandemic, the subjects will answer a question in the survey addressing if they have had a financial loss during the pandemic. This question will have the following answer options: no financial loss, less than 25% financial loss, between 25-50%, between 50-75%, more than 75% of financial loss due the pandemic.
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Trate - Tratamentos Especializados

Investigators

  • Principal Investigator: MARCELO B BOTELHO, DC, MD, MSc, Trate

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 26, 2020

Primary Completion (Anticipated)

September 6, 2020

Study Completion (Anticipated)

September 18, 2020

Study Registration Dates

First Submitted

August 25, 2020

First Submitted That Met QC Criteria

August 30, 2020

First Posted (Actual)

September 1, 2020

Study Record Updates

Last Update Posted (Actual)

September 1, 2020

Last Update Submitted That Met QC Criteria

August 30, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TrateTE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Collective / group data sharing only.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Clinical Trials on Electronic survey

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe